0003-2814 : Orencia 50 mg/.4ml Subcutaneous Injection, Solution


NDC0003-2814
Labeler: E.r. Squibb & Sons, L.L.C.
Product Type: Human Prescription Drug
Drug Name:  Orencia
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA125118
Rev. Date: 


NDC Package Codes:

  • 0003-2814-11: 4 SYRINGE, GLASS IN 1 CARTON (0003‑2814‑11) > .4 ML IN 1 SYRINGE, GLASS

Active Ingredients:

  • Abatacept

Dosage Strength:

  • 50 mg/.4mL

Pharmaceutical Classes:

  • Decreased Cytokine Activity [PE]
  • Selective T Cell Costimulation Modulator [EPC]
  • Recombinant Fusion Proteins [CS]

Related Products:

Based on records with the same trade name.
  • 0003-2187 Orencia 250 mg/15ml Intravenous Injection, Powder, Lyophilized, for Solution by E.r. Squibb & Sons, L.L.C.
  • 0003-2188 Orencia 125 mg/ml Subcutaneous Injection, Solution by E.r. Squibb & Sons, L.L.C.
  • 0003-2818 Orencia 87.5 mg/.7ml Subcutaneous Injection, Solution by E.r. Squibb & Sons, L.L.C.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0003-2814 QR Code

< Prev: 0003-2570Next: 0003-2818 >

Related Discussions:

Giant Cell Arteritis/Abatacept Study
We are interested in finding out whether abatacept has been successful in treating Giant Cell Arteritis, before joining ...
orencia
orencia possibly causing chest pain,shortness or breath? ## It sounds like you may be having an allergic reaction to thi... 2 replies




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 14 July 2017.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA